Recent rulings have shifted evidentiary burdens in algorithms-as-agent litigation. As autonomous decision systems replace human discretion in high-stakes financial and medical contexts, trial courts are confronted with unprecedented questions of culpability and duty of care.
In this treatise review, we analyze whether existing product liability jurisprudence provides adequate remedy, or whether legislative intervention is required.
